|
|
|
|
LEADER |
00000cam a2200000Ia 4500 |
001 |
11121665 |
005 |
20210426223521.4 |
006 |
m o d |
007 |
cr cn||||||||| |
008 |
111205s2011 dcua ob 100 0 eng d |
016 |
7 |
|
|a 101582836
|2 DNLM
|
016 |
7 |
|
|a 016066521
|2 Uk
|
019 |
|
|
|a 760055026
|a 772459094
|a 971092635
|a 988460703
|a 991919289
|a 1037929686
|a 1038664408
|a 1045551101
|a 1047527785
|a 1058168116
|a 1153534888
|
020 |
|
|
|a 9780309219297
|q (e-book)
|
020 |
|
|
|a 0309219299
|q (e-book)
|
020 |
|
|
|a 9780309219303
|q (electronic bk.)
|
020 |
|
|
|a 0309219302
|q (electronic bk.)
|
020 |
|
|
|z 0309219299
|
035 |
|
|
|a (OCoLC)769188485
|z (OCoLC)760055026
|z (OCoLC)772459094
|z (OCoLC)971092635
|z (OCoLC)988460703
|z (OCoLC)991919289
|z (OCoLC)1037929686
|z (OCoLC)1038664408
|z (OCoLC)1045551101
|z (OCoLC)1047527785
|z (OCoLC)1058168116
|z (OCoLC)1153534888
|
035 |
|
9 |
|a (OCLCCM-CC)769188485
|
040 |
|
|
|a E7B
|b eng
|e pn
|c E7B
|d IDEBK
|d N$T
|d MMU
|d YDXCP
|d TPH
|d OCLCQ
|d CDX
|d UCNAP
|d ZMC
|d OCLCQ
|d OCLCA
|d OCLCF
|d NLGGC
|d COO
|d OCLCQ
|d VT2
|d OCLCQ
|d AGLDB
|d TOA
|d MOR
|d OCLCO
|d PIFAG
|d OCLCQ
|d OCLCA
|d BUF
|d OCLCO
|d STF
|d VNS
|d WRM
|d VTS
|d NRAMU
|d EZ9
|d ICG
|d MERER
|d REC
|d AU@
|d OCLCQ
|d OCLCO
|d LVT
|d M8D
|d OCLCQ
|d OCLCO
|d OCLCA
|d UKCRE
|d AJS
|
043 |
|
|
|a n-us---
|
049 |
|
|
|a MAIN
|
050 |
|
4 |
|a R853.C55
|b P83 2011eb
|
060 |
|
4 |
|a QV 771
|
072 |
|
7 |
|a MED
|x 047000
|2 bisacsh
|
111 |
2 |
|
|a Public Engagement and Clinical Trials: New Models and Disruptive Technologies
|d (2011 :
|c Mount Sinai School of Medicine)
|0 http://id.loc.gov/authorities/names/no2012029643
|
245 |
1 |
0 |
|a Public engagement and clinical trials :
|b new models and disruptive technologies : workshop summary /
|c Victoria Weisfeld, Rebecca A. English, and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies.
|
260 |
|
|
|a Washington, D.C. :
|b National Academies Press,
|c 2011.
|
300 |
|
|
|a 1 online resource (xvi, 124 pages) :
|b color illustrations
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
504 |
|
|
|a Includes bibliographical references (pages 85-87).
|
520 |
|
|
|a "Clinical trials provide essential information needed to turn basic medical research findings into patient treatments. New treatments must be studied in large numbers of humans to find out whether they are effective and to assess any harm that may arise from treatment. There is growing recognition among many stakeholders that the U.S. clinical trials enterprise is unable to keep pace with the national demand for research results. The IOM, along with the Mount Sinai School of Medicine, held a workshop June 27-28, 2011, to engage stakeholders and experts in a discussion about possible solutions to improve public engagement in clinical trials"--Publisher's description.
|
505 |
0 |
0 |
|t Introduction --
|t Framing the problem --
|t Recruitment challenges in clinical trials for different diseases and conditions --
|t Models for public health engagement --
|t The media --
|t Novel clinical trial designs --
|t The health system's structure and culture --
|t Toward a patient-centered strategy for clinical trials.
|
650 |
|
0 |
|a Clinical trials.
|0 http://id.loc.gov/authorities/subjects/sh85027069
|
650 |
1 |
2 |
|a Clinical Trials as Topic.
|
650 |
1 |
2 |
|a Patient Participation.
|
650 |
2 |
2 |
|a Drug Evaluation.
|
650 |
2 |
2 |
|a Patient Education as Topic.
|
651 |
|
2 |
|a United States.
|
650 |
|
7 |
|a MEDICAL
|x Laboratory Medicine.
|2 bisacsh
|
650 |
|
7 |
|a Clinical trials.
|2 fast
|0 (OCoLC)fst00864429
|
655 |
|
0 |
|a Electronic books.
|
655 |
|
4 |
|a Electronic resource.
|
655 |
|
4 |
|a Electronic books.
|
700 |
1 |
|
|a Weisfeld, Victoria D.
|0 http://id.loc.gov/authorities/names/n89630070
|
700 |
1 |
|
|a English, Rebecca A.
|0 http://id.loc.gov/authorities/names/no2010177259
|
700 |
1 |
|
|a Claiborne, Anne B.
|0 http://id.loc.gov/authorities/names/no2011029945
|
710 |
2 |
|
|a Institute of Medicine (U.S.).
|b Forum on Drug Discovery, Development, and Translation.
|0 http://id.loc.gov/authorities/names/no2007051854
|
776 |
0 |
8 |
|i Print version:
|t Public Engagement and Clinical Trials.
|d Washington, D.C. : National Academies Press, ©2011
|z 9780309219297
|w (OCoLC)767570602
|
856 |
4 |
0 |
|u http://dx.doi.org/10.17226/13237
|y National Academies Press
|
856 |
4 |
0 |
|u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=e000xna&AN=400080
|y eBooks on EBSCOhost
|
903 |
|
|
|a HeVa
|
929 |
|
|
|a oclccm
|
999 |
f |
f |
|i 0c91018b-535a-5a04-b70a-75caab81c366
|s 354c65ef-4e19-56b2-aaa7-1bee21bda35b
|
928 |
|
|
|t Library of Congress classification
|a R853.C55 P83 2011eb
|l Online
|c UC-FullText
|u http://dx.doi.org/10.17226/13237
|z National Academies Press
|g ebooks
|i 12360691
|
928 |
|
|
|t Library of Congress classification
|a R853.C55 P83 2011eb
|l Online
|c UC-FullText
|u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=e000xna&AN=400080
|z eBooks on EBSCOhost
|g ebooks
|i 12360692
|